Of note, CERAD scores provide an estimate of neuritic plaque burden which represent both amyloid‐β and tau (dystrophic neurites) deposition and more reliably predict cognitive impairment [36], hence our finding of an association between CERAD scores and hearing impairment could be a statistical artefact whereby higher CERAD score is a proxy measure for presence of cognitive impairment, with the latter driving the association between CERAD score and hearing impairment. The gene discussed is MAPT; the disease is Cognitive impairment.